Global Nicotine Replacement Therapy Market: Industry Analysis and Forecast (2021-2027) by Product Type, Distributions Channels, and Region

Global Nicotine Replacement Therapy Market size was valued at US$ 51.2 Bn in 2020 and the total revenue is expected to grow at 16.3% through 2021 to 2027, reaching nearly US$ 148 Bn.

Global Nicotine Replacement Therapy Market Overview:

Cigarette smoking is a chronic health concern that affects people all over the world. The negative economic and health impacts of smoking have received more attention. Tobacco contains nicotine, which is addictive, and tobacco use almost always results in nicotine addiction. Nicotine replacement therapy (NRT) products and medicines are the most common smoking cessation aids, and they can be used with counseling and psychotherapy. During the process of quitting smoking, however, some nicotine withdrawal symptoms such as anxiety and irritability are noted, leading to the person's resumption of smoking. Global Nicotine Replacement Therapy Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2027. 2020 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done good in lockdown also and specific strategic analysis of those companies is done in the report.

Global Nicotine Replacement Therapy Market Dynamics:

The rise in Nicotine Replacement therapy can be linked to a growing number of technical improvements as well as a surge in the number of persons who use nicotine replacement treatment (NRT). Growing public awareness of the effects of tobacco is likely to be a major driver of the industry. Globally, the number of individuals who smoke is increasing and has already reached 1.4 billion. People are opting for smoking cessation therapy as a result of government measures such as the "affordable care act," provisions, and campaigns to raise knowledge about the detrimental effects of smoking on health through counseling. In 2019, % of the 33.9 million smokers in the U. S. attempted to quit. Scientific modifications in the nicotine replacement treatment market are progressing, increasing the number of persons who are shifting to sophisticated products. The popularity of NRT is anticipated to be assisted by innovations such as heat-not-burn products, flavored chewing gums, and lozenges. Tobacco companies such as British American Tobacco have developed smokeless and less toxic alternatives. When opposed to traditional cigarettes, these advances have a flexible range of efficacy and are acceptable in society, pushing their acceptance and enhancing market growth. The prohibition on e-cigarettes, on the other extreme, is one of the most significant challenges to the market's expansion. The Indian government, for example, prohibited the import, manufacture, and sale of e-cigarettes in September 2019. India is a country with approximately 100 million smokers, so this factor has huge market potential. Other countries, including Mexico, Brazil, Malaysia, and Thailand, have prohibited the use, import, and manufacture of e-cigarettes. By 2025, over 20 countries will have restricted the use of e-cigarettes. The market's growth is likely to be harmed as a result of this.

Global Nicotine Replacement Therapy Market Segment Analysis:

The E-cigarettes segment is dominating the Product Type segment of the Global Nicotine Replacement Therapy Market:

In 2020, e-cigarettes had the highest market share of 52.23 %. E-cigarettes are becoming increasingly popular, and they are commonly recognized in the majority of nations. E-cigarettes have an adherence rate of around 17%, which is greater than the average abstinence rate of 9.7% for comparable NRT products. E-cigarettes were used by 3.2 % of individuals in the Us in 2018. According to the Wiley Journal, 18 % who use patches in combination with another kind of NRT can quit smoking in 2019, whereas 14 % can quit using only one type of NRT. According to the research, goods with a greater nicotine content (4 mg) are more likely to provide beneficial effects than those with a dilute solution (2 mg). further, there are various tobacco favor gums such as Chewing Tobacco, sublingual tablets, nicotine gums and lozenges, and various others stimulating the market expansion in the future. Global Nicotine Replacement Therapy Market 1

The offline segment is considered to supplement the growth of the Global Nicotine Replacement Therapy Market.

The offline sector will account for 83.9 % of revenue in 2020. The accessibility of Nicotine Replacement Therapy (NRT) items like transdermal patches, gels, gums, e-cigarettes, and heated tobacco products at big stores such as retail pharmacies and Walmart Stores etc. has supported the segment's development. Furthermore, hospital collaborations with these chains aid in the growth of the firm. The internet industry is expected to grow at the fastest rate throughout the forecasted timeframe. The comfort, flexibility, and convenience provided by online pharmacy purchases are significant factors propelling the business. Discounts offered by internet pharmacies are also likely to fuel category growth.

Global Nicotine Replacement Therapy Market Regional Insights:

In 2020, North America had a significant market share. The growing incidence of smoking-related problems and the rise in the number of beneficial government efforts, together with rising acceptance of e-cigarettes and heated tobacco, are projected to boost the North American market's growth. The dominating countries of North America are Canada, Mexico, and US., and the US is leading among all. The U. S. Food and Drug Administration (FDA) approved the sale and distribution of Philip Morris Products S.A.'s IQOS Tobacco Heating System in April 2020. The product is an electrical machine that produces aerosols by heating prefilled tobacco sticks. Furthermore, GlaxoSmithKline plc. launched Nicorette, a mint-flavored nicotine lozenge, as an over-the-counter medication in May 2019. Hence, rapid innovations and product launches by market players in the US are likely to fuel the growth of the market in the forecast period. Global Nicotine Replacement Therapy Market 2 The objective of the report is to present a comprehensive analysis of the Global  Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Nicotine Replacement Therapy Market dynamics, structure by analyzing the market segments and project the Global Nicotine Replacement Therapy Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Nicotine Replacement Therapy Market make the report investor’s guide.

Global Nicotine Replacement Therapy Market Scope: Inquire before buying

Global Nicotine Replacement Therapy Market 3

Global Nicotine Replacement Therapy Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Global Nicotine Replacement Therapy Market Key Player

Philip Morris Products S.A. (Altria Group) • British American Tobacco p.l.c. • Japan Tobacco, Inc. • Imperial Brands • Glenmark • Fertin Pharma • Cipla Inc. • Pfizer Inc. • Johnson & Johnson Services, Inc • GlaxoSmithKline plc • McNeil AB, NJOY, Inc. • Novartis International AG • Revolymer PLC • Takeda Pharmaceutical Co., Ltd. • Perrigo Company Plc • Pierre Fabre SA, Laboratories

FAQs:

1. What is the global Nicotine Replacement Therapy market value in 2020? Ans: Global Nicotine Replacement Therapy market value in 2020 was estimated as 51.2 Billion USD. 2. What is the global Nicotine Replacement Therapy market growth? Ans: The global Nicotine Replacement Therapy market is anticipated to grow with a CAGR of 16.3 % in the forecast period and is likely to reach USD 148 Billion by the end of 2027. 3. Which Product Type segment is expected to dominate the global Nicotine Replacement Therapy market during the forecast period? Ans: E-cigarettes dominated the NRT market with a share of 52.23% in 2020. This is attributable to its large-scale usage and increasing adoption. These products are commonly adopted by younger consumers, although, adoption is increasing steadily among middle-aged consumers. 4. Who are the key players in the nicotine replacement therapy market? Ans: Some key players operating in the NRT market include Pfizer Inc., British American Tobacco p.l.c., Cipla Inc., Glenmark, Imperial Brands, Japan Tobacco, Inc., Philip Morris Products S.A., Fertin Pharma, and Johnson & Johnson Services, Inc. 5. What is the key driving factor for the growth of the global Nicotine Replacement Therapy market? Ans: Key factors that are driving the NRT market growth include a growing number of technological advancements and an increasing number of people undergoing nicotine replacement therapy.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Nicotine Replacement Therapy Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Nicotine Replacement Therapy Market 3.4. Geographical Snapshot of the Nicotine Replacement Therapy Market, By Manufacturer share 4. Global Nicotine Replacement Therapy Market Overview, 2021-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Nicotine Replacement Therapy Market 5. Supply Side and Demand Side Indicators 6. Global Nicotine Replacement Therapy Market Analysis and Forecast, 2021-2027 6.1. Global Nicotine Replacement Therapy Market Size & Y-o-Y Growth Analysis. 7. Global Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 7.1. Market Size (Value) Estimates & Forecast By Specimen, 2021-2027 7.1.1. Nicotine Replacement Therapy 7.1.1.1. Inhalers 7.1.1.2. Gum 7.1.1.3. Transdermal Patches 7.1.1.4. Sublingual Tablets 7.1.1.5. Lozenges 7.1.1.6. Others 7.1.2. E-cigarettes 7.1.3. Heat-not-burn Tobacco Products 7.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 7.2.1. Offline 7.2.2. Online 8. Global Nicotine Replacement Therapy Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 9.1. Market Size (Value) Estimates & Forecast By Specimen, 2021-2027 9.1.1. Nicotine Replacement Therapy 9.1.1.1. Inhalers 9.1.1.2. Gum 9.1.1.3. Transdermal Patches 9.1.1.4. Sublingual Tablets 9.1.1.5. Lozenges 9.1.1.6. Others 9.1.2. E-cigarettes 9.1.3. Heat-not-burn Tobacco Products 9.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 9.2.1. Offline 9.2.2. Online 10. North America Nicotine Replacement Therapy Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 11.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 11.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 12. Canada Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 12.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 12.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 13. Mexico Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 13.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 13.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 14. Europe Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 14.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 14.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 15. Europe Nicotine Replacement Therapy Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 16.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 16.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 17. France Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 17.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 17.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 18. Germany Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 18.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 18.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 19. Italy Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 19.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 19.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 20. Spain Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 20.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 20.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 21. Sweden Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 21.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 21.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 22. CIS Countries Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 22.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 22.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 23. Rest of Europe Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 23.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 23.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 24. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 24.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 24.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 25. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 26.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 26.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 27. India Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 27.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 27.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 28. Japan Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 28.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 28.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 29. South Korea Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 29.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 29.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 30. Australia Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 30.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 30.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 31. ASEAN Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 31.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 31.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 32. Rest of Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 32.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 32.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 33. Middle East Africa Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 33.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 33.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 34. Middle East Africa Nicotine Replacement Therapy Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 35.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 35.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 36. GCC Countries Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 36.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 36.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2021-2027 37.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 37.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 38. Nigeria Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 38.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 38.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 39. Rest of ME&A Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 39.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 39.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 40. South America Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 40.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 40.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 41. South America Nicotine Replacement Therapy Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 42.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 42.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 43. Argentina Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 43.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 43.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 44. Rest of South America Nicotine Replacement Therapy Market Analysis and Forecasts, 2021-2027 44.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2027 44.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2021-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Nicotine Replacement Therapy Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Glenmark 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Philip Morris Products S.A. (Altria Group) 45.3.3. British American Tobacco p.l.c. 45.3.4. Japan Tobacco, Inc. 45.3.5. Imperial Brands 45.3.6. Fertin Pharma 45.3.7. Cipla Inc. 45.3.8. Pfizer Inc. 45.3.9. Johnson & Johnson Services, Inc 45.3.10. GlaxoSmithKline plc 45.3.11. McNeil AB, NJOY, Inc. 45.3.12. Novartis International AG 45.3.13. Revolymer PLC 45.3.14. Takeda Pharmaceutical Co., Ltd. 45.3.15. Perrigo Company Plc 45.3.16. Pierre Fabre SA, Laboratories 46. Primary Key Insights

About This Report

Report ID 119526
Category Healthcare
Published Date Sept 2021
Updated Date
Contact Us